newsfilter
← Latest News
GlobeNewswire·

Sema4 to Participate at Two Upcoming Investor Conferences in February

STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following virtual investor conferences: BT